[
  {
    "objectID": "index.html",
    "href": "index.html",
    "title": "STARS Work Package 1",
    "section": "",
    "text": "Overview\nThis book describes the findings from work package 1 of the project STARS: Sharing Tools and Artefacts for Reproducible Simulations in healthcare.\nUse the sidebar to navigate through:",
    "crumbs": [
      "<span class='chapter-number'>1</span>Â  <span class='chapter-title'>Overview</span>"
    ]
  },
  {
    "objectID": "index.html#overview",
    "href": "index.html#overview",
    "title": "STARS Work Package 1",
    "section": "",
    "text": "Introduction - background on the STARS project, pilot work, and the aim of work package 1\nMethods - summarises the methods which are described in detail in our protocol\nResults - describes the results of the reproductions and evaluations, and reflections from the process\nDiscussion - considers and applies findings",
    "crumbs": [
      "<span class='chapter-number'>1</span>Â  <span class='chapter-title'>Overview</span>"
    ]
  },
  {
    "objectID": "index.html#funding",
    "href": "index.html#funding",
    "title": "STARS Work Package 1",
    "section": "Funding",
    "text": "Funding\nThis work is supported by the Medical Research Council [grant number MR/Z503915/1].",
    "crumbs": [
      "<span class='chapter-number'>1</span>Â  <span class='chapter-title'>Overview</span>"
    ]
  },
  {
    "objectID": "index.html#license",
    "href": "index.html#license",
    "title": "STARS Work Package 1",
    "section": "License",
    "text": "License\nThis book is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) license.",
    "crumbs": [
      "<span class='chapter-number'>1</span>Â  <span class='chapter-title'>Overview</span>"
    ]
  },
  {
    "objectID": "pages/background.html",
    "href": "pages/background.html",
    "title": "2Â  STARS",
    "section": "",
    "text": "TODO: Add background about STARS, pilot work, and aim of WP1",
    "crumbs": [
      "<span class='chapter-number'>2</span>Â  <span class='chapter-title'>Introduction</span>"
    ]
  },
  {
    "objectID": "pages/protocol.html",
    "href": "pages/protocol.html",
    "title": "3Â  Protocol",
    "section": "",
    "text": "The protocol for this work is summarised in the diagram below and archived on Zenodo:\n\nHeather, A., Monks, T., Harper, A., Mustafee, N., & Mayne, A. (2024). Protocol for assessing the computational reproducibility of discrete-event simulation models on STARS. Zenodo. https://doi.org/10.5281/zenodo.12179846.\n\n\n\n\nWorkflow for STARS work package 1",
    "crumbs": [
      "<span class='chapter-number'>3</span>Â  <span class='chapter-title'>Methods</span>"
    ]
  },
  {
    "objectID": "pages/reproduction.html",
    "href": "pages/reproduction.html",
    "title": "4Â  Reproduction",
    "section": "",
    "text": "4.1 Studies\nShoaib and Ramamohan (2021): This is a discrete-event simulation modelling primary health centres (PHCs) in India. There are four patient types: outpatients, inpatients, childbirth cases and antenatal care patients. Four model configurations are developed based on observed PHC practices or government-mandated operational guidelines. The paper explores different operational patterns for scenarios where very high utilisation was observed, to explore what might help reduce utilisation of these resources. (Article published as Shoaib and Ramamohan (2022), but we used the green open access pre-print)\nHuang et al. (2019): This is a discrete-event simulation model of an endovascular clot retrieval (ECR) service. ECR is a treatment for acute ischaemic stroke. The model includes the stroke pathway, as well as three other pathways that share resources with the stroke pathway: an elective non-stroke interventional neuroradiology pathway, an emergency interventional radiology pathway, and an elective interventional radiology pathway. The model is created using R Simmer. The paper explores waiting times and resource utilisation - particularly focussing on the biplane angiographic suite (angioINR). A few scenarios are tried to help examine why the wait times are so high for the angioINR.\nLim et al. (2020): This is a discrete-event simulation modelling the transmission of COVID-19 in laboratory. It examines the proportion of staff infected in scenarios varying the: number of shifts per day; number of staff per shift; overall staff pool; shift patterns; secondary attack rate of the virus; introduction of protective measures (social distancing and personal protective equipment). The model is created using Python.\nKim et al. (2021): This study adapts a previously developed discrete-event simulation model for abdominal aortic aneurysm (AAA) screening of men in England. It aims to explore different approaches to resuming screening and surgical repair for AAA, as these survives were paused or substantially reduced during COVID-19 due to concerns about virus transmission.\nAnagnostou et al. (2022): This paper includes two models - we have focussed just on the dynamiC Hospital wARd Management (CHARM) model. CHARM is a discrete-event simulation modelling intensive care units (ICU) in the COVID-19 pandemic (as well as subsequent stays in a recovery bed). It includes three types of admission to the ICU (emergency, elective or COVID-19). COVID-19 patients are kept seperate, and if they run out of capacity due to a surge in COVID-19 admissions, additional capacity can be pooled from the elective and emergency capacity.\nJohnson et al. (2021): TBC",
    "crumbs": [
      "Results",
      "<span class='chapter-number'>4</span>Â  <span class='chapter-title'>Reproduction</span>"
    ]
  },
  {
    "objectID": "pages/reproduction.html#scope",
    "href": "pages/reproduction.html#scope",
    "title": "4Â  Reproduction",
    "section": "4.2 Scope",
    "text": "4.2 Scope\n\n\n\n\n\n\n\n\n\nStudy\nScope\nSuccess\nTime\n\n\n\n\nShoaib and Ramamohan 2022\n17 items:â€¢ 1 tableâ€¢ 9 figuresâ€¢ 7 in-text results\n16 out of 17 (94%)\n28h 14m\n\n\nHuang et al.Â 2019\n8 items:â€¢ 5 figuresâ€¢ 3 in-text results\n3 out of 8 (37.5%)\n24h 10m\n\n\nLim et al.Â 2020\n9 items:â€¢ 5 tablesâ€¢ 4 figures\n9 out of 9 (100%)\n12h 27m\n\n\nKim et al.Â 2021\n10 items:â€¢ 3 tablesâ€¢ 6 figuresâ€¢ 1 in-text result\n10 out of 10 (100%)\n13h 59m\n\n\nAnagnostou et al.Â 2022\n1 item:â€¢ 1 figure\n1 out of 1 (100%)\n2h 10m\n\n\nJohnson et al.Â 2021\n5 items:â€¢ 1 tableâ€¢ 4 figures\nTBC\nTBC",
    "crumbs": [
      "Results",
      "<span class='chapter-number'>4</span>Â  <span class='chapter-title'>Reproduction</span>"
    ]
  },
  {
    "objectID": "pages/reproduction.html#time-to-completion",
    "href": "pages/reproduction.html#time-to-completion",
    "title": "4Â  Reproduction",
    "section": "4.3 Time to completion",
    "text": "4.3 Time to completion\n\nNon-interactive figure:\n\n\n\n\n\n\n\n\n\nInteractive figure:",
    "crumbs": [
      "Results",
      "<span class='chapter-number'>4</span>Â  <span class='chapter-title'>Reproduction</span>"
    ]
  },
  {
    "objectID": "pages/reproduction.html#references",
    "href": "pages/reproduction.html#references",
    "title": "4Â  Reproduction",
    "section": "4.4 References",
    "text": "4.4 References\n\n\n\n\nAnagnostou, Anastasia, Derek Groen, Simon J. E. Taylor, Diana Suleimenova, Nura Abubakar, Arindam Saha, Kate Mintram, et al. 2022. â€œFACS-CHARM: A Hybrid Agent-Based and Discrete-Event Simulation Approach for Covid-19 Management at Regional Level.â€ In 2022 Winter Simulation Conference (WSC), 1223â€“34. https://doi.org/10.1109/WSC57314.2022.10015462.\n\n\nHuang, Shiwei, Julian Maingard, Hong Kuan Kok, Christen D. Barras, Vincent Thijs, Ronil V. Chandra, Duncan Mark Brooks, and Hamed Asadi. 2019. â€œOptimizing Resources for Endovascular Clot Retrieval for Acute Ischemic Stroke, a Discrete Event Simulation.â€ Frontiers in Neurology 10 (June). https://doi.org/10.3389/fneur.2019.00653.\n\n\nJohnson, Kate M., Mohsen Sadatsafavi, Amin Adibi, Larry Lynd, Mark Harrison, Hamid Tavakoli, Don D. Sin, and Stirling Bryan. 2021. â€œCost Effectiveness of Case Detection Strategies for the Early Detection of COPD.â€ Applied Health Economics and Health Policy 19 (2): 203â€“15. https://doi.org/10.1007/s40258-020-00616-2.\n\n\nKim, Lois G., Michael J. Sweeting, Morag Armer, Jo Jacomelli, Akhtar Nasim, and Seamus C. Harrison. 2021. â€œModelling the Impact of Changes to Abdominal Aortic Aneurysm Screening and Treatment Services in England During the COVID-19 Pandemic.â€ PLOS ONE 16 (6): e0253327. https://doi.org/10.1371/journal.pone.0253327.\n\n\nLim, Chun Yee, Mary Kathryn Bohn, Giuseppe Lippi, Maurizio Ferrari, Tze Ping Loh, Kwok-Yung Yuen, Khosrow Adeli, and Andrea Rita Horvath. 2020. â€œStaff Rostering, Split Team Arrangement, Social Distancing (Physical Distancing) and Use of Personal Protective Equipment to Minimize Risk of Workplace Transmission During the COVID-19 Pandemic: A Simulation Study.â€ Clinical Biochemistry 86 (December): 15â€“22. https://doi.org/10.1016/j.clinbiochem.2020.09.003.\n\n\nShoaib, Mohd, and Varun Ramamohan. 2021. â€œSimulation Modelling and Analysis of Primary Health Centre Operations.â€ arXiv, June. https://doi.org/10.48550/arXiv.2104.12492.\n\n\nâ€”â€”â€”. 2022. â€œSimulation Modeling and Analysis of Primary Health Center Operations.â€ SIMULATION 98 (3): 183â€“208. https://doi.org/10.1177/00375497211030931.",
    "crumbs": [
      "Results",
      "<span class='chapter-number'>4</span>Â  <span class='chapter-title'>Reproduction</span>"
    ]
  },
  {
    "objectID": "pages/reflections.html",
    "href": "pages/reflections.html",
    "title": "5Â  Reflections from reproductions",
    "section": "",
    "text": "TODO: Table with reflections from each study",
    "crumbs": [
      "Results",
      "<span class='chapter-number'>5</span>Â  <span class='chapter-title'>Reflections from reproductions</span>"
    ]
  },
  {
    "objectID": "pages/repo_evaluation.html",
    "href": "pages/repo_evaluation.html",
    "title": "6Â  Evaluation of the repository",
    "section": "",
    "text": "TODO: Add table with results from evaluation of repository against STARS framework and against journal badges. Include record of timings to complete this part of the evaluation for each.",
    "crumbs": [
      "Results",
      "<span class='chapter-number'>6</span>Â  <span class='chapter-title'>Evaluation of the repository</span>"
    ]
  },
  {
    "objectID": "pages/paper_evaluation.html",
    "href": "pages/paper_evaluation.html",
    "title": "7Â  Evaluation of the article",
    "section": "",
    "text": "7.1 Summary\nSTRESS-DES:\nDES checklist derived from ISPOR-SDM:",
    "crumbs": [
      "Results",
      "<span class='chapter-number'>7</span>Â  <span class='chapter-title'>Evaluation of the article</span>"
    ]
  },
  {
    "objectID": "pages/paper_evaluation.html#stress-des",
    "href": "pages/paper_evaluation.html#stress-des",
    "title": "7Â  Evaluation of the article",
    "section": "7.2 STRESS-DES",
    "text": "7.2 STRESS-DES\n\nKey:\n\nS: Shoaib and Ramamohan (2021) - link to evaluation\nH: Huang et al. (2019) - link to evaluation\nL: Lim et al. (2020) - link to evaluation\nK: Kim et al. (2021) - link to evaluation\nA: Anagnostou et al. (2022) - link to evaluation\nJ: Johnson et al. (2021) - link to evaluation\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nItem\nS\nH\nL\nK\nA\nJ\n\n\n\n\n\nObjectives\n\n\n\n\n\n\n\n\n\n1.1 Purpose of the modelExplain the background and objectives for the model\nâœ…\nâœ…\nâœ…\nâœ…\nâœ…\n\n\n\n\n1.2 Model outputsDefine all quantitative performance measures that are reported, using equations where necessary. Specify how and when they are calculated during the model run along with how any measures of error such as confidence intervals are calculated.\nğŸŸ¡\nâœ…\nâœ…\nâœ…\nâœ…\n\n\n\n\n1.3 Experimentation aimsIf the model has been used for experimentation, state the objectives that it was used to investigate.(A) Scenario based analysis â€“ Provide a name and description for each scenario, providing a rationale for the choice of scenarios and ensure that item 2.3 (below) is completed.(B) Design of experiments â€“ Provide details of the overall design of the experiments with reference to performance measures and their parameters (provide further details in data below).(C) Simulation Optimisation â€“ (if appropriate) Provide full details of what is to be optimised, the parameters that were included and the algorithm(s) that was be used. Where possible provide a citation of the algorithm(s).\nâœ…\nâœ…\nâœ…\nâœ…\nN/A\n\n\n\n\nLogic\n\n\n\n\n\n\n\n\n\n2.1 Base model overview diagramDescribe the base model using appropriate diagrams and description. This could include one or more process flow, activity cycle or equivalent diagrams sufficient to describe the model to readers. Avoid complicated diagrams in the main text. The goal is to describe the breadth and depth of the model with respect to the system being studied.\nâœ…\nâœ…\nâœ…\ntbc\nâœ…\n\n\n\n\n2.2 Base model logicGive details of the base model logic. Give additional model logic details sufficient to communicate to the reader how the model works.\nâœ…\nâœ…\nâœ…\ntbc\nâœ…\n\n\n\n\n2.3 Scenario logicGive details of the logical difference between the base case model and scenarios (if any). This could be incorporated as text or where differences are substantial could be incorporated in the same manner as 2.2.\nâœ…\nâœ…\nâœ…\nâœ…\nN/A\n\n\n\n\n2.4 AlgorithmsProvide further detail on any algorithms in the model that (for example) mimic complex or manual processes in the real world (i.e.Â scheduling of arrivals/ appointments/ operations/ maintenance, operation of a conveyor system, machine breakdowns, etc.). Sufficient detail should be included (or referred to in other published work) for the algorithms to be reproducible. Pseudo-code may be used to describe an algorithm.\nâœ…\nğŸŸ¡\nâœ…\ntbc\nâœ…\n\n\n\n\n2.5.1 Components - entitiesGive details of all entities within the simulation including a description of their role in the model and a description of all their attributes.\nâœ…\nâœ…\nâœ…\nâœ…\nâœ…\n\n\n\n\n2.5.2 Components - activitiesDescribe the activities that entities engage in within the model. Provide details of entity routing into and out of the activity.\nâœ…\nâœ…\nâœ…\ntbc\nâœ…\n\n\n\n\n2.5.3 Components - resourcesList all the resources included within the model and which activities make use of them.\nâœ…\nâœ…\nN/A\ntbc\nâœ…\n\n\n\n\n2.5.4 Components - queuesGive details of the assumed queuing discipline used in the model (e.g.Â First in First Out, Last in First Out, prioritisation, etc.). Where one or more queues have a different discipline from the rest, provide a list of queues, indicating the queuing discipline used for each. If reneging, balking or jockeying occur, etc., provide details of the rules. Detail any delays or capacity constraints on the queues.\nâœ…\nâœ…\nN/A\ntbc\nâœ…\n\n\n\n\n2.5.5 Components - entry/exit pointsGive details of the model boundaries i.e.Â all arrival and exit points of entities. Detail the arrival mechanism (e.g.Â â€˜thinningâ€™ to mimic a non-homogenous Poisson process or balking)\nâœ…\nâœ…\nâœ…\nâœ…\nâœ…\n\n\n\n\nData\n\n\n\n\n\n\n\n\n\n3.1 Data sourcesList and detail all data sources. Sources may include:â€¢ Interviews with stakeholders,â€¢ Samples of routinely collected data,â€¢ Prospectively collected samples for the purpose of the simulation study,â€¢ Public domain data published in either academic or organisational literature. Provide, where possible, the link and DOI to the data or reference to published literature.All data source descriptions should include details of the sample size, sample date ranges and use within the study.\nâœ…\nâœ…\nâœ…\nâœ…\nâœ…\n\n\n\n\n3.2 Pre-processingProvide details of any data manipulation that has taken place before its use in the simulation, e.g.Â interpolation to account for missing data or the removal of outliers.\nâœ…\nN/A\nN/A\nâœ…\nN/A\n\n\n\n\n3.3 Input parametersList all input variables in the model. Provide a description of their use and include parameter values. For stochastic inputs provide details of any continuous, discrete or empirical distributions used along with all associated parameters. Give details of all time dependent parameters and correlation.Clearly state:â€¢ Base case dataâ€¢ Data use in experimentation, where different from the base case.â€¢ Where optimisation or design of experiments has been used, state the range of values that parameters can take.â€¢ Where theoretical distributions are used, state how these were selected and prioritised above other candidate distributions.\nğŸŸ¡\nğŸŸ¡\nâœ…\nğŸŸ¡\nâœ…\n\n\n\n\n3.4 AssumptionsWhere data or knowledge of the real system is unavailable what assumptions are included in the model? This might include parameter values, distributions or routing logic within the model.\nâœ…\nâŒ\nâœ…\nâœ…\nâŒ\n\n\n\n\nExperimentation\n\n\n\n\n\n\n\n\n\n4.1 InitialisationReport if the system modelled is terminating or non-terminating. State if a warm-up period has been used, its length and the analysis method used to select it. For terminating systems state the stopping condition.State what if any initial model conditions have been included, e.g., pre-loaded queues and activities. Report whether initialisation of these variables is deterministic or stochastic.\nğŸŸ¡\nâŒ\nâŒ\ntbc\nâŒ\n\n\n\n\n4.2 Run lengthDetail the run length of the simulation model and time units.\nâœ…\nâœ…\nâœ…\nâœ…\nğŸŸ¡\n\n\n\n\n4.3 Estimation approachState the method used to account for the stochasticity: For example, two common methods are multiple replications or batch means. Where multiple replications have been used, state the number of replications and for batch means, indicate the batch length and whether the batch means procedure is standard, spaced or overlapping. For both procedures provide a justification for the methods used and the number of replications/size of batches.\nğŸŸ¡\nğŸŸ¡\nâœ…\nâœ…\nâœ…\n\n\n\n\nImplementation\n\n\n\n\n\n\n\n\n\n5.1 Software or programming languageState the operating system and version and build number.State the name, version and build number of commercial or open source DES software that the model is implemented in.State the name and version of general-purpose programming languages used (e.g.Â Python 3.5).Where frameworks and libraries have been used provide all details including version numbers.\nğŸŸ¡\nğŸŸ¡\nğŸŸ¡\nğŸŸ¡\nğŸŸ¡\n\n\n\n\n5.2 Random samplingState the algorithm used to generate random samples in the software/programming language used e.g.Â Mersenne Twister.If common random numbers are used, state how seeds (or random number streams) are distributed among sampling processes.\nâŒ\nğŸŸ¡\nâŒ\nâŒ\nâŒ\n\n\n\n\n5.3 Model executionState the event processing mechanism used e.g.Â three phase, event, activity, process interaction.Note that in some commercial software the event processing mechanism may not be published. In these cases authors should adhere to item 5.1 software recommendations.State all priority rules included if entities/activities compete for resources.If the model is parallel, distributed and/or use grid or cloud computing, etc., state and preferably reference the technology used. For parallel and distributed simulations the time management algorithms used. If the HLA is used then state the version of the standard, which run-time infrastructure (and version), and any supporting documents (FOMs, etc.)\nğŸŸ¡\nâŒ\nâŒ\ntbc\nâŒ\n\n\n\n\n5.4 System specificationState the model run time and specification of hardware used. This is particularly important for large scale models that require substantial computing power. For parallel, distributed and/or use grid or cloud computing, etc. state the details of all systems used in the implementation (processors, network, etc.)\nâœ…\nâŒ\nğŸŸ¡\ntbc\nâŒ\n\n\n\n\nCode access\n\n\n\n\n\n\n\n\n\n6.1 Computer model sharing statementDescribe how someone could obtain the model described in the paper, the simulation software and any other associated software (or hardware) needed to reproduce the results. Provide, where possible, the link and DOIs to these.\nâœ…\nâœ…\nâœ…\nâœ…\nâœ…",
    "crumbs": [
      "Results",
      "<span class='chapter-number'>7</span>Â  <span class='chapter-title'>Evaluation of the article</span>"
    ]
  },
  {
    "objectID": "pages/paper_evaluation.html#des-checklist-derived-from-ispor-sdm",
    "href": "pages/paper_evaluation.html#des-checklist-derived-from-ispor-sdm",
    "title": "7Â  Evaluation of the article",
    "section": "7.3 DES checklist derived from ISPOR-SDM",
    "text": "7.3 DES checklist derived from ISPOR-SDM\nKey:\n\nS: Shoaib and Ramamohan (2021) - link to evaluation\nH: Huang et al. (2019) - link to evaluation\nL: Lim et al. (2020) - link to evaluation\nK: Kim et al. (2021) - link to evaluation\nA: Anagnostou et al. (2022) - link to evaluation\nJ: Johnson et al. (2021) - link to evaluation\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nItem\nS\nH\nL\nK\nA\nJ\n\n\n\n\n\nModel conceptualisation\n\n\n\n\n\n\n\n\n\n1 Is the focused health-related decision problem clarified?â€¦the decision problem under investigation was defined. DES studies included different types of decision problems, eg, those listed in previously developed taxonomies.\nâœ…\nâœ…\nâœ…\nâœ…\nâœ…\n\n\n\n\n2 Is the modeled healthcare setting/health condition clarified?â€¦the physical context/scope (eg, a certain healthcare unit or a broader system) or disease spectrum simulated was described.\nâœ…\nâœ…\nâœ…\nâœ…\nâœ…\n\n\n\n\n3 Is the model structure described?â€¦the modelâ€™s conceptual structure was described in the form of either graphical or text presentation.\nâœ…\nâœ…\nâœ…\ntbc\nâœ…\n\n\n\n\n4 Is the time horizon given?â€¦the time period covered by the simulation was reported.\nâœ…\nâœ…\nâœ…\nâœ…\nâœ…\nâŒ\n\n\n\n5 Are all simulated strategies/scenarios specified?â€¦the comparators under test were described in terms of their components, corresponding variations, etc\nâœ…\nâœ…\nâœ…\nâœ…\nâœ…\nN/A\n\n\n\n6 Is the target population described?â€¦the entities simulated and their main attributes were characterized.\nâœ…\nâŒ\nâœ…\nâœ…\nğŸŸ¡\n\n\n\n\nParamaterisation and uncertainty assessment\n\n\n\n\n\n\n\n\n\n7 Are data sources informing parameter estimations provided?â€¦the sources of all data used to inform model inputs were reported.\nâœ…\nâœ…\nâœ…\nâœ…\nâœ…\n\n\n\n\n8 Are the parameters used to populate model frameworks specified?â€¦all relevant parameters fed into model frameworks were disclosed.\nğŸŸ¡\nğŸŸ¡\nâœ…\nâœ…\nâœ…\n\n\n\n\n9 Are model uncertainties discussed?â€¦the uncertainty surrounding parameter estimations and adopted statistical methods (eg, 95% confidence intervals or possibility distributions) were reported.\nğŸŸ¡\nâŒ\nâŒ\nâŒ\nâœ…\n\n\n\n\n10 Are sensitivity analyses performed and reported?â€¦the robustness of model outputs to input uncertainties was examined, for example via deterministic (based on parametersâ€™ plausible ranges) or probabilistic (based on a priori-defined probability distributions) sensitivity analyses, or both.\nâœ…\nâŒ\nâœ…\nâŒ\nN/A\n\n\n\n\nValidation\n\n\n\n\n\n\n\n\n\n11 Is face validity evaluated and reported?â€¦it was reported that the model was subjected to the examination on how well model designs correspond to the reality and intuitions. It was assumed that this type of validation should be conducted by external evaluators with no stake in the study.\nâŒ\nâŒ\nâŒ\nâŒ\nâŒ\n\n\n\n\n12 Is cross validation performed and reportedâ€¦comparison across similar modeling studies which deal with the same decision problem was undertaken.\nN/A\nâŒ\nâŒ\nâœ…\nâŒ\n\n\n\n\n13 Is external validation performed and reported?â€¦the modeler(s) examined how well the modelâ€™s results match the empirical data of an actual event modeled.\nN/A\nN/A\nN/A\nâœ…\nâŒ\n\n\n\n\n14 Is predictive validation performed or attempted? â€¦the modeler(s) examined the consistency of a modelâ€™s predictions of a future event and the actual outcomes in the future. If this was not undertaken, it was assessed whether the reasons were discussed.\nN/A\nN/A\nN/A\nN/A\nN/A\n\n\n\n\nGeneralisability and stakeholder involvement\n\n\n\n\n\n\n\n\n\n15 Is the model generalizability issue discussed?â€¦the modeler(s) discussed the potential of the resulting model for being applicable to other settings/populations (single/multiple application).\nâœ…\nâœ…\nâœ…\nâŒ\nğŸŸ¡\n\n\n\n\n16 Are decision makers or other stakeholders involved in modeling?â€¦the modeler(s) reported in which part throughout the modeling process decision makers and other stakeholders (eg, subject experts) were engaged.\nâŒ\nâŒ\nâŒ\nâŒ\nâœ…\n\n\n\n\n17 Is the source of funding stated?â€¦the sponsorship of the study was indicated.\nâœ…\nâŒ\nâœ…\nâœ…\nâœ…\n\n\n\n\n18 Are model limitations discussed?â€¦limitations of the assessed model, especially limitations of interest to decision makers, were discussed.\nâœ…\nğŸŸ¡\nâœ…\nâœ…\nğŸŸ¡",
    "crumbs": [
      "Results",
      "<span class='chapter-number'>7</span>Â  <span class='chapter-title'>Evaluation of the article</span>"
    ]
  },
  {
    "objectID": "pages/paper_evaluation.html#timings",
    "href": "pages/paper_evaluation.html#timings",
    "title": "7Â  Evaluation of the article",
    "section": "7.4 Timings",
    "text": "7.4 Timings",
    "crumbs": [
      "Results",
      "<span class='chapter-number'>7</span>Â  <span class='chapter-title'>Evaluation of the article</span>"
    ]
  },
  {
    "objectID": "pages/paper_evaluation.html#references",
    "href": "pages/paper_evaluation.html#references",
    "title": "7Â  Evaluation of the article",
    "section": "7.5 References",
    "text": "7.5 References\n\n\n\n\nAnagnostou, Anastasia, Derek Groen, Simon J. E. Taylor, Diana Suleimenova, Nura Abubakar, Arindam Saha, Kate Mintram, et al. 2022. â€œFACS-CHARM: A Hybrid Agent-Based and Discrete-Event Simulation Approach for Covid-19 Management at Regional Level.â€ In 2022 Winter Simulation Conference (WSC), 1223â€“34. https://doi.org/10.1109/WSC57314.2022.10015462.\n\n\nHuang, Shiwei, Julian Maingard, Hong Kuan Kok, Christen D. Barras, Vincent Thijs, Ronil V. Chandra, Duncan Mark Brooks, and Hamed Asadi. 2019. â€œOptimizing Resources for Endovascular Clot Retrieval for Acute Ischemic Stroke, a Discrete Event Simulation.â€ Frontiers in Neurology 10 (June). https://doi.org/10.3389/fneur.2019.00653.\n\n\nJohnson, Kate M., Mohsen Sadatsafavi, Amin Adibi, Larry Lynd, Mark Harrison, Hamid Tavakoli, Don D. Sin, and Stirling Bryan. 2021. â€œCost Effectiveness of Case Detection Strategies for the Early Detection of COPD.â€ Applied Health Economics and Health Policy 19 (2): 203â€“15. https://doi.org/10.1007/s40258-020-00616-2.\n\n\nKim, Lois G., Michael J. Sweeting, Morag Armer, Jo Jacomelli, Akhtar Nasim, and Seamus C. Harrison. 2021. â€œModelling the Impact of Changes to Abdominal Aortic Aneurysm Screening and Treatment Services in England During the COVID-19 Pandemic.â€ PLOS ONE 16 (6): e0253327. https://doi.org/10.1371/journal.pone.0253327.\n\n\nLim, Chun Yee, Mary Kathryn Bohn, Giuseppe Lippi, Maurizio Ferrari, Tze Ping Loh, Kwok-Yung Yuen, Khosrow Adeli, and Andrea Rita Horvath. 2020. â€œStaff Rostering, Split Team Arrangement, Social Distancing (Physical Distancing) and Use of Personal Protective Equipment to Minimize Risk of Workplace Transmission During the COVID-19 Pandemic: A Simulation Study.â€ Clinical Biochemistry 86 (December): 15â€“22. https://doi.org/10.1016/j.clinbiochem.2020.09.003.\n\n\nMonks, Thomas, Christine S. M. Currie, Bhakti Stephan Onggo, Stewart Robinson, Martin Kunc, and Simon J. E. Taylor. 2019. â€œStrengthening the Reporting of Empirical Simulation Studies: Introducing the STRESS Guidelines.â€ Journal of Simulation 13 (1): 55â€“67. https://doi.org/10.1080/17477778.2018.1442155.\n\n\nShoaib, Mohd, and Varun Ramamohan. 2021. â€œSimulation Modelling and Analysis of Primary Health Centre Operations.â€ arXiv, June. https://doi.org/10.48550/arXiv.2104.12492.\n\n\nZhang, Xiange, Stefan K. Lhachimi, and Wolf H. Rogowski. 2020. â€œReporting Quality of Discrete Event Simulations in Healthcareâ€”Results From a Generic Reporting Checklist.â€ Value in Health 23 (4): 506â€“14. https://doi.org/10.1016/j.jval.2020.01.005.",
    "crumbs": [
      "Results",
      "<span class='chapter-number'>7</span>Â  <span class='chapter-title'>Evaluation of the article</span>"
    ]
  }
]